Firalis - Press Releases

Home
About
Services
Products
R&D
Quality
Investors
Media
Careers
IFU APO-Easy
Stability APO-Easy

Contact

Home
About
Services
Products
R&D
Quality
Investors
Media

Press Releases

Bpifrance funds Firalis’ Alzheimer Project!

FIRALIS’ Research on Neurodegenerative Diseases obtains Bpifrance Funding!

09.08.2022

FIRALIS obtains ISO 14001 International Quality Standard !

FIRALIS obtained the AFNOR certification “ISO 14001”, a gold standard in improving the environmental performance!

11.07.2022

HAS valide le remboursement d'EasyCOV*

*La Haute Autorité de Santé (HAS) valide l’utilisation et recommande le remboursement du test salivaire EasyCOV® sous conditions.

28.11.2020

TACKLING COVID-19: THE "COVIRNA" PROJECT

A diagnostic test funded by the EU, to improve surveillance and care of COVID-19 patients

27.11.2020

EasyCov: Covid-19 saliva test

Firalis-produced and CE-marked "EasyCOV" saliva test, developed by Skillcell

18.06.2020

EU-funded (Eurostars) HeartLinc Program

13.03.2020

Fundraising by Amoneta Diagnostics

13.03.2020

USD 2 million by the Alzheimer’s Drug Discovery Foundation ...

13.03.2020

Champions de la croissance 2020

Firalis is placed as the 229th fastest growing French business in 2020, among 10k participants, as a result of a selection by the partnership of "Les Echos" and "Statista".

13.03.2020

Amoneta closes 2019 with fundraising of EUR 2.2 million

11.01.2020

Contact Firalis

Firalis Group

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE

Press Releases

Bpifrance funds Firalis’ Alzheimer Project!

FIRALIS obtains ISO 14001 International Quality Standard !

HAS valide le remboursement d'EasyCOV*

TACKLING COVID-19: THE "COVIRNA" PROJECT

EasyCov: Covid-19 saliva test

Theranostic Tool

EU-funded (Eurostars) HeartLinc Program

Launch of the Biopred panel

Launch of the FiMICS® panel

Fundraising by Amoneta Diagnostics

USD 2 million by the Alzheimer’s Drug Discovery Foundation ...

Champions de la croissance 2020

Amoneta closes 2019 with fundraising of EUR 2.2 million

Firalis Group